Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Apremilast showed mixed results for treating severe alopecia areata.

No link found between blood groups, Rhesus factor, and ferritin levels in women with hair loss.

FFA in men shows unique features and treatment results vary widely.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Frontal fibrosing alopecia can mimic traction alopecia but has distinct features like facial papules and eyebrow thinning.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

XiaoZhenFang (XZF) can help prevent skin problems caused by certain cancer drugs.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

The patient has frontal fibrosing alopecia (FFA).

Early diagnosis and quick treatment improve life quality for FFA patients.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

A group has developed therapies that show promise for treating cancer and various other conditions.

Ritlecitinib is safe and may effectively treat alopecia areata.

Exposure to certain glycol ethers during pregnancy may be linked to lower verbal comprehension in children.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Fructus Psoraleae may help treat hair loss by inhibiting 5-α reductase and affecting the Nrf2-Keap1 pathway.

The Annurca apple supplement significantly improved hair growth in people with hair loss.

A unique type of hair loss mimics another condition but has minimal inflammation and specific immune cells present.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

New therapies are needed to reduce the burden of alopecia areata.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

A specific protein in chicken embryos links early skin layers to feather development.

Powdered milk in Senegal has varying heavy metal levels, with some exceeding safety limits, needing more regulation.